Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshifumi Aoyama

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 24, 2004
[Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis]Naoki Tanaka, Toshifumi Aoyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2006
[PPAR and NASH]Naoki Tanaka, Toshifumi Aoyama
Pharmacology & Therapeutics|May 27, 2017
Targeting nuclear receptors for the treatment of fatty liver diseaseNaoki Tanaka, Toshifumi Aoyama, Shioko Kimura, et al.
Pflugers Archiv : European Journal of Physiology|February 15, 2018
PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca<sup>2+</sup> channels with full-length Ca<sub>V</sub>1.2 C-terminusXiaoguang Guo, Toshihide Kashihara, Tsutomu Nakada, et al.
International Journal of Cancer|September 4, 2007
Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesisNaoki Tanaka, Kyoji Moriya, Kendo Kiyosawa, et al.
Nagoya Journal of Medical Science|February 13, 2003
Functional activation of peroxisome proliferator-activated receptor alpha (PPARalpha) by environmental chemicals in relation to their toxicitiesTamie Nakajima, Gaku Ichihara, Michihiro Kamijima, et al.
Biochimica Et Biophysica Acta|June 5, 2003
Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null miceJeffrey M Peters, Toshifumi Aoyama, Amanda M Burns, et al.
Industrial Health|November 22, 2005
A review of hazardous chemical toxicity studies utilizing genetically-modified animals--their applications for risk assessmentTamie Nakajima, Rui-Sheng Wang, Yuki Ito, et al.
Lipids|March 13, 2008
Molecular mechanism of age-specific hepatic lipid accumulation in PPARalpha (+/-):LDLR (+/-) mice, an obese mouse modelYufeng Li, Eiko Sugiyama, Shin Yokoyama, et al.
Archives of Toxicology|August 29, 2006
Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosetsYuki Ito, Osamu Yamanoshita, Yoshimasa Kurata, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 24, 2004
[Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis]Naoki Tanaka, Toshifumi Aoyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2006
[PPAR and NASH]Naoki Tanaka, Toshifumi Aoyama
Pharmacology & Therapeutics|May 27, 2017
Targeting nuclear receptors for the treatment of fatty liver diseaseNaoki Tanaka, Toshifumi Aoyama, Shioko Kimura, et al.
Pflugers Archiv : European Journal of Physiology|February 15, 2018
PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca<sup>2+</sup> channels with full-length Ca<sub>V</sub>1.2 C-terminusXiaoguang Guo, Toshihide Kashihara, Tsutomu Nakada, et al.
International Journal of Cancer|September 4, 2007
Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesisNaoki Tanaka, Kyoji Moriya, Kendo Kiyosawa, et al.
Nagoya Journal of Medical Science|February 13, 2003
Functional activation of peroxisome proliferator-activated receptor alpha (PPARalpha) by environmental chemicals in relation to their toxicitiesTamie Nakajima, Gaku Ichihara, Michihiro Kamijima, et al.
Biochimica Et Biophysica Acta|June 5, 2003
Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null miceJeffrey M Peters, Toshifumi Aoyama, Amanda M Burns, et al.
Industrial Health|November 22, 2005
A review of hazardous chemical toxicity studies utilizing genetically-modified animals--their applications for risk assessmentTamie Nakajima, Rui-Sheng Wang, Yuki Ito, et al.
Lipids|March 13, 2008
Molecular mechanism of age-specific hepatic lipid accumulation in PPARalpha (+/-):LDLR (+/-) mice, an obese mouse modelYufeng Li, Eiko Sugiyama, Shin Yokoyama, et al.
Archives of Toxicology|August 29, 2006
Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosetsYuki Ito, Osamu Yamanoshita, Yoshimasa Kurata, et al.
Pageof 9